Traditional Chinese medicine could potentially serve as an effective alternative therapy for managing Psoriasis vulgaris.
The methodology for this study involved reviewing controlled clinical trials regarding Traditional Chinese Medicine's (TCM) use for Psoriasis vulgaris (PV) treatment, conducted within the past decade. Over 2000 papers were considered, from which 17 high-quality articles were selectively reviewed. Aspects such as design defects, small sample size, and inadequate intervention time in some trials were noted, affecting their potential for full clarification of TCM's role in PV treatment.
Results from the accumulated data insinuated that Traditional Chinese Medicine might hold the multi-target advantage to substantially lower the Psoriasis Area and Severity Index (PASI) scores, thereby benefiting PV management. In addition to its potential efficacy, the safety of using TCM for treating Psoriasis vulgaris was also evaluated during this review.
